PA2G4 and hepatocellular carcinoma: At the same time the half-life of FYN mRNA following treatment with the RNA synthesis inhibitor actinomycin D was shorter in HCC cells with PA2G4 knockdown than in corresponding control cells, indicating that PA2G4 increased the stability of FYN mRNA (Fig. 5A).